Coldstream Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-524
| Closed | -$67K | – | 2123 |
|
2025
Q1 | $67K | Buy |
+524
| New | +$67K | ﹤0.01% | 1546 |
|
2023
Q2 | – | Sell |
-4,258
| Closed | -$550K | – | 842 |
|
2023
Q1 | $550K | Sell |
4,258
-1,821
| -30% | -$235K | 0.02% | 406 |
|
2022
Q4 | $798K | Buy |
+6,079
| New | +$798K | 0.03% | 301 |
|
2022
Q2 | $783K | Buy |
+6,654
| New | +$783K | 0.03% | 273 |
|
2017
Q4 | – | Sell |
-2,142
| Closed | -$238K | – | 321 |
|
2017
Q3 | $238K | Buy |
+2,142
| New | +$238K | 0.03% | 265 |
|